{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:42:51Z","timestamp":1791272571897,"version":"4.1.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Panic disorder is characterized by sudden panic attacks and persistent anticipatory anxiety. While pharmacotherapy remains effective, patients with panic disorder often experience residual symptoms and functional impairments. Lifestyle factors influence symptom severity but are often unaddressed in routine psychiatric care. Most current digital therapeutics for panic disorder have a limited scope, lack integration with clinicians, and fail to consider behavioral patterns. To address these limitations, our research team developed a prescription-based app that supports structured cognitive behavioral therapy practice, real-life symptom management, and lifestyle modifications for patients with panic disorder, and a management console\u2014a web-based platform that allows clinicians to monitor the patients\u2019 engagement and progress as well as determine therapeutic options if necessary.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to test the usability of the app and management console by evaluating their interface, functionality, and user experience. The primary goal was to identify the strengths and areas for further improvement of these software devices and to develop a list of modifications to improve the user experience and clinical applicability in updates to refine the devices for a future clinical trial.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Usability data were collected by investigators at a medical device usability research center without the involvement of the development research team, and the participants were 15 patients with panic disorder and 15 psychiatrists. Each group completed experimental use of the app or management console and scored the convenience and safety of its modules, questionnaire evaluations for the acceptability, and presentation of verbal subjective feedback on areas for improvement. Based on the participants\u2019 suggestions, a list of items that need to be modified to improve functionality and ease of use for each device was created.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Patients completed 155 assigned tasks for the app with more than 98% success, and psychiatrists completed 34 tasks for the management console with more than 86% success. The convenience and safety scores for the app and management console exceeded the neutral threshold (mean >4.5). For all statements about the acceptability, both patients and psychiatrists responded at the level of agreeing with a score exceeding 3 (mean: 3.6~4.3 and 4~4.7, respectively). There were 38 suggestions for app improvements and 66 suggestions for management console improvements, most of which were incorporated in the modification list.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Patients reported that the app might be easy to use and help manage anxiety, and psychiatrists found the management console practical and well-suited for outpatients. By combining patient-facing therapeutic tools with clinician-driven prescription and monitoring, the devices offer a solution aligned with clinically integrated, real-world psychiatric care. Modified devices based on the improvement suggestions presented in this study will be evaluated in future clinical trials for their impact on engagement and treatment outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/76843","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:42:31Z","timestamp":1760730151000},"page":"e76843-e76843","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Usability of a Prescription-Based Mobile App for Patients With Panic Disorder and Its Management Console for Clinicians: Controlled User Study"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-9343","authenticated-orcid":false,"given":"Yujin","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0767-191X","authenticated-orcid":false,"given":"Jeemin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6708-8451","authenticated-orcid":false,"given":"Kyunghee","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-2797","authenticated-orcid":false,"given":"Yesol","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-9438","authenticated-orcid":false,"given":"Yu-Bin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-0810","authenticated-orcid":false,"given":"Choongki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5194-6712","authenticated-orcid":false,"given":"Kyungnam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-3549","authenticated-orcid":false,"given":"Wonseuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6837-1621","authenticated-orcid":false,"given":"Hayeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1395-4562","authenticated-orcid":false,"given":"Jae-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"6","key":"R1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/da.22277","article-title":"Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes","volume":"31","author":"Asmundson","journal-title":"Depress Anxiety"},{"issue":"11","key":"R2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012729.pub3","article-title":"Pharmacological treatments in panic disorder in adults: a network meta-analysis","volume":"11","author":"Guaiana","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/acps.12169","article-title":"Cost-effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder","volume":"129","author":"van Apeldoorn","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4088\/JCP.08m04681blu","article-title":"A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up","volume":"71","author":"van Apeldoorn","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"R5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1017\/S0033291717003919","article-title":"Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis","volume":"48","author":"Pompoli","journal-title":"Psychol Med"},{"issue":"3","key":"R6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1017\/S0033291722003683","article-title":"CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials","volume":"53","author":"Papola","journal-title":"Psychol Med"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14737175.2021.2005581","article-title":"Can regular physical exercise be a treatment for panic disorder? A systematic review","volume":"22","author":"Machado","journal-title":"Expert Rev Neurother"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2021.11.005","article-title":"Effects of caffeine on anxiety and panic attacks in patients with panic disorder: a systematic review and meta-analysis","volume":"74","author":"Klevebrant","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4088\/pcc.v10n0411d","article-title":"Panic disorder after the end of chronic alcohol abuse: a report of 2 cases","volume":"10","author":"Canan","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"7","key":"R10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/archpsyc.60.7.692","article-title":"Smoking increases the risk of panic: findings from a prospective community study","volume":"60","author":"Isensee","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10484-020-09465-0","article-title":"Evaluating the impact of freespira on panic disorder patients\u2019 health outcomes and healthcare costs within the allegheny health network","volume":"45","author":"Kaplan","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","DOI":"10.2196\/32982","article-title":"A digital therapeutic intervention delivering biofeedback for panic attacks (panicmechanic): feasibility and usability study","volume":"6","author":"McGinnis","journal-title":"JMIR Form Res"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.2196\/51428","article-title":"The effectiveness of a digital app for reduction of clinical symptoms in individuals with panic disorder: randomized controlled trial","volume":"26","author":"Kim","journal-title":"J Med Internet Res"},{"issue":"5","key":"R14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14051771","article-title":"Digital cognitive behavioral therapy for panic disorder and agoraphobia: a meta-analytic review of clinical components to maximize efficacy","volume":"14","author":"Jung","journal-title":"J Clin Med"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.976001","article-title":"Real-world outcomes of an innovative digital therapeutic for treatment of panic disorder and PTSD: a 1,500 patient effectiveness study","volume":"4","author":"Cuyler","journal-title":"Front Digit Health"},{"issue":"Suppl 1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14 Suppl 1","author":"Katzman","journal-title":"BMC Psychiatry"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/j.1440-1614.2003.01254.x","article-title":"Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia","volume":"37","author":"Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia","journal-title":"Aust N Z J Psychiatry"},{"issue":"27-28","key":"R18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3238\/arztebl.2014.0473","article-title":"The diagnosis of and treatment recommendations for anxiety disorders","volume":"111","author":"Bandelow","journal-title":"Dtsch Arztebl Int"},{"key":"R19","volume":"58 Suppl 2","author":"Barlow","journal-title":"J Clin Psychiatry"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/809653","article-title":"Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence","volume":"2012","author":"Sarris","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"R21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1017\/S1352465812000057","article-title":"Anticipatory anxiety as a function of panic attacks and panic-related self-efficacy: an ambulatory assessment study in panic disorder","volume":"40","author":"Helbig-Lang","journal-title":"Behav Cogn Psychother"},{"issue":"6","key":"R22","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.3390\/ijerph120607017","article-title":"Lifestyle behaviours add to the armoury of treatment options for panic disorder: an evidence-based reasoning","volume":"12","author":"Lambert","journal-title":"Int J Environ Res Public Health"},{"key":"R23","unstructured":"Nielsen J . Heuristic evaluation. In: Nielsen J Mack RL , editors. Usability Inspection Methods. John Wiley & Sons; 1994:25-62. [doi: 10.5555\/189200.189209] ISBN: 0471018775"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Brooke J . SUS: a \u201cquick and dirty\u201d usability scale. In: Jordan PW Thomas B Weerdmeester BA McClelland AL , editors. Usability Evaluation in Industry. Taylor and Francis; 1996:189-194. [doi: 10.1201\/9781498710411]","DOI":"10.1201\/9781498710411"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Lewis JR . Psychometric evaluation of the post-study system usability questionnaire: the PSSUQ. Presented at: Proceedings of the Human Factors Society Annual Meeting; Oct 12-16, 1992; Atlanta, Georgia. [doi: 10.1177\/154193129203601617]","DOI":"10.1177\/154193129203601617"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2016.02.001","article-title":"Treatment-resistant panic disorder: clinical significance, concept and management","volume":"70","author":"Chen","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"R27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.brat.2005.05.003","article-title":"One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission","volume":"44","author":"Heldt","journal-title":"Behav Res Ther"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/ndt.s1224","article-title":"Pharmacotherapy of panic disorder","volume":"4","author":"Pull","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"R29","first-page":"563","volume":"34","author":"Austin","journal-title":"Aust Fam Physician"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Lee J Kawai T Yoshida N et al. A usability assessment on a virtual reality system for panic disorder treatment. Presented at: Electronic Imaging 2008; Jan 28 to Feb 1, 2008; San Jose, CA. [doi: 10.1117\/12.766461]","DOI":"10.1117\/12.766461"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/j.invent.2019.100296","article-title":"A mobile application for panic disorder and agoraphobia: insights from a multi-methods feasibility study","volume":"19","author":"Ebenfeld","journal-title":"Internet Interv"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e76843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:08:43Z","timestamp":1782842923000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e76843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/76843","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"v9i6e76843"}}